dc.contributor.author | Demirel, Müzeyyen | |
dc.contributor.author | Yazan, Yasemin | |
dc.date.accessioned | 2019-10-19T16:02:42Z | |
dc.date.available | 2019-10-19T16:02:42Z | |
dc.date.issued | 2001 | |
dc.identifier.issn | 1300-4182 | |
dc.identifier.uri | https://hdl.handle.net/11421/13878 | |
dc.description.abstract | Piribedil is a dopamin agonist with vasodilator activity and whose aqueous solubility is low and elimination half-life is short. It is widely used in cerebral ageing and in Parkinson's disease. Literature on physico-chemical and pharmacological properties, analysis methods, bioavailability and pharmacokinetics of piribedil has been reviewed in this article. | en_US |
dc.language.iso | tur | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Bioavailability | en_US |
dc.subject | Pharmacokinetics | en_US |
dc.subject | Physico-Chemical Characteristics | en_US |
dc.subject | Piribedil | en_US |
dc.title | Bioavailability file: Piribedil [Biyoyararlanim dosyasi: Piribedil] | en_US |
dc.type | review | en_US |
dc.relation.journal | Fabad Journal of Pharmaceutical Sciences | en_US |
dc.contributor.department | Anadolu Üniversitesi, Eczacılık Fakültesi, Farmasötik Teknoloji Anabilim Dalı | en_US |
dc.identifier.volume | 26 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 205 | en_US |
dc.identifier.endpage | 217 | en_US |
dc.relation.publicationcategory | Diğer | en_US] |
dc.contributor.institutionauthor | Demirel, Müzeyyen | |
dc.contributor.institutionauthor | Yazan, Yasemin | |